Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Net Income (2016 - 2025)

Historic Net Income for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $237000.0.

  • Champions Oncology's Net Income fell 6744.51% to $237000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.4 million, marking a year-over-year increase of 50652.17%. This contributed to the annual value of $4.7 million for FY2025, which is 16460.97% up from last year.
  • Champions Oncology's Net Income amounted to $237000.0 in Q4 2025, which was down 6744.51% from -$466000.0 recorded in Q3 2025.
  • Over the past 5 years, Champions Oncology's Net Income peaked at $4.5 million during Q1 2025, and registered a low of -$2.6 million during Q3 2023.
  • Its 5-year average for Net Income is -$365250.0, with a median of -$245500.0 in 2021.
  • Its Net Income has fluctuated over the past 5 years, first skyrocketed by 2760000.0% in 2021, then tumbled by 1284375.0% in 2023.
  • Over the past 5 years, Champions Oncology's Net Income (Quarter) stood at $277000.0 in 2021, then tumbled by 105.78% to -$16000.0 in 2022, then plummeted by 12843.75% to -$2.1 million in 2023, then skyrocketed by 135.15% to $728000.0 in 2024, then tumbled by 67.45% to $237000.0 in 2025.
  • Its Net Income stands at $237000.0 for Q4 2025, versus -$466000.0 for Q3 2025 and -$1.8 million for Q2 2025.